Business
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated in
About this update from Glucotrack, Inc.
[{"type":"image","alt":"Glucotrack, Inc.","displaySize":"","headline":null,"caption":"Glucotrack, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/55d126c2f85c074ae4df3a352637b3fb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RRdXPZplYJ.hxgfOveDirA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/55d126c2f85c074ae4df3a352637b3fb","width":300,"height":64}},"lazy":false},{"type":"text","content":"Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes study","length":118,"tagName":"p"},{"type":"text","content":"RUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery system that will enable optimal glucose control without patient intervention.","length":474,"tagName":"p"},{"type":"text","content":"FORGETDIABETES is funded by the European Union's Horizon 2020 research and innovation program, a multi-year funding program with €75 Billion to support initiatives ranging from basic research to innovative product development. The groundbreaking FORGETDIABETES initiative is dedicated to developing a bionic invisible pancreas, which will free people with type 1 diabetes from therapeutic actions and the related psychological burden. Glucotrack’s Continuous Blood Glucose Monitor (CBGM) will provide real-time glucose readings to drive insulin delivery decisions for the bionic pancreas system.","length":599,"tagName":"p"},{"type":"text","content":"“We are committed to the goal of revolutionizing treatment for people with type 1 diabetes, forever changing the medical approach towards this disease burden,” said Claudio Cobelli, PhD, Emeritus Professor of Bioengineering at the University of Padova in Padova, Italy, who serves as Coordinator for the initiative. “The longevity, accuracy and convenience of Glucotrack’s CBGM make it more automatic and less intrusive to daily living than other glucose monitoring methods and thus an ide...